Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Other Non-Current Assets (2020 - 2026)

PROCEPT BioRobotics has reported Other Non-Current Assets over the past 7 years, most recently at $3.0 million for Q1 2026.

  • Quarterly Other Non-Current Assets rose 2.98% to $3.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Mar 2026, up 2.98% year-over-year, with the annual reading at $3.0 million for FY2025, 18.9% up from the prior year.
  • Other Non-Current Assets was $3.0 million for Q1 2026 at PROCEPT BioRobotics, roughly flat from $3.0 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $4.3 million in Q2 2025 and troughed at $51000.0 in Q4 2022.
  • The 5-year median for Other Non-Current Assets is $3.0 million (2023), against an average of $2.3 million.
  • The largest YoY upside for Other Non-Current Assets was 5856.86% in 2023 against a maximum downside of 98.66% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $51000.0 in 2022, then surged by 5856.86% to $3.0 million in 2023, then decreased by 15.9% to $2.6 million in 2024, then increased by 18.9% to $3.0 million in 2025, then changed by 0.0% to $3.0 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Other Non-Current Assets are $3.0 million (Q1 2026), $3.0 million (Q4 2025), and $3.0 million (Q3 2025).